NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Deepull

Deepull

Private
BarcelonaHealthcare & Life Scienceshttps://deepull.com/

Last Round

Series C

Apr 29, 2025

Total Funding Raised

$102.8M

Company Overview

Deepull is a medical diagnostics company developing a culture-free diagnostic system for the rapid, direct-from-blood detection of pathogens and antibiotic resistance associated with sepsis.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware + Subscription

AI Layer

Non-AI

Keywords

sepsis detectionIVDin-vitro diagnosticsbloodstream infectionmolecular diagnosticspathogen identificationrapid diagnosticsmultiplex PCRclinical diagnosticspoint of care testingPOCTculture-free diagnosticsmedical devicesepsis managementdiagnostic platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Deepull Comps

Public and private peers based on sector, stage, and business model.

Deepull comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Deepull Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CApr 29, 2025
Series B ExtensionMar 1, 2023
DebtDec 5, 2022
Series BOct 20, 2022
Series AJul 7, 2020

Key People

Founding team and executive leadership

Jordi Carrera

Co-Founder & CEO

Founding Team

Pilar Casado Garcia

CFO

Executive Team

Bruno Monschau

Chief Operations Officer (COO)

Executive Team

Deepull Investors

Notable investors and investment history

Deepull investors
InvestorRounds
Asabys PartnersSeries C, Series B, Series B Extension
AXIS Participaciones EmpresarialesSeries C, Series A, Series B
Alta Life SciencesSeries B Extension, Series B, Series A
We Venture CapitalSeries C
CG Health VenturesSeries C
Axis Participaciones EmpresarialesSeries B Extension, Series A, Series B
UI InvestissementSeries C, Series B Extension, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 29, 2025

    $57M round closed.

Deepull Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Deepull Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Deepull's valuation, stock price, and market status.

Firmographic Details

HeadquartersBarcelona
Employee Range68
Year Founded2020
Last FundingApr 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.